• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建立具有不同转移潜能的大鼠肝癌细胞系。

Establishment of rat liver cancer cell lines with different metastatic potential.

机构信息

Department of Laboratory Animal Science of Hebei Medical University, Heibei Key Laboratory of Laboratory Animals, Shijiazhuang, 050017, Hebei, China.

Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin, 300193, China.

出版信息

Sci Rep. 2020 May 20;10(1):8329. doi: 10.1038/s41598-020-65338-w.

DOI:10.1038/s41598-020-65338-w
PMID:32433581
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7239898/
Abstract

The gloomy outcome of liver cancer is mainly due to the high rates of metastasis and recurrence, even after curative resection for early stage liver cancer. Our study was conducted to find the animal model suitable for the study of liver cancer metastasis. In our study, two liver cancer cells were obtained from N-nitrosodiethylamine (DEN) and N-nitrosomorpholine (NMOR) induced rats, and they were cultivated, screened and cloning cultivated. Bionomics of cells was analyzed. The results show that 2 cells had different metastatic potentiality. They were named Wrh-f2 and Wrh-s2, and they have the characteristics of Hepatocellular carcinoma cells. The bionomics of 2 cells showed: (1) The chromosome karyotype analysis showed that the mode of Wrh-f2 was 80-83 and Wrh-s2 was 55-57; (2) AFP positive cytoplasmic staining was observed in Wrh-f2 and Wrh-s2. Cytokeratin (CK) 7 and CK8 positive staining was present in Wrh-f2. CK8 positive staining was present in Wrh-s2; (3) The numbers of Wrh-f2 and Wrh-s2 that passed through the Transwells were 98 ± 12 and 55 ± 15;(4) Wrh-f2 had the significant higher colony formation (78%) than Wrh-s2(8%) (P < 0.01). (5) The animal models generated solid tumours when 2 cells were inoculated to nude mouse and rat. And Wrh-f2 developed stable pulmonary metastasis. The established cell lines with different metastatic potential showed obvious advantages over liver cancer in mimicking the biological properties of malignant liver cancer tumors. It provided a suitable model for the mechanism of liver cancer metastasis in vivo and in vitro.

摘要

肝癌预后不佳主要是由于即使对早期肝癌进行根治性切除后,仍存在高转移和复发率。本研究旨在寻找适合研究肝癌转移的动物模型。本研究从 N-亚硝基二乙胺(DEN)和 N-亚硝基吗啉(NMOR)诱导的大鼠中获得了两种肝癌细胞,并对其进行了培养、筛选和克隆培养。分析了细胞的生物学特性。结果表明,这两种细胞具有不同的转移潜能,分别命名为 Wrh-f2 和 Wrh-s2,具有肝癌细胞的特征。两种细胞的生物学特性如下:(1)染色体核型分析显示,Wrh-f2 的模式为 80-83,Wrh-s2 的模式为 55-57;(2)Wrh-f2 和 Wrh-s2 的细胞质中均有 AFP 阳性染色,Wrh-f2 中 CK7 和 CK8 阳性染色,Wrh-s2 中 CK8 阳性染色;(3)穿过 Transwell 的 Wrh-f2 和 Wrh-s2 的数量分别为 98±12 和 55±15;(4)Wrh-f2 的集落形成率(78%)明显高于 Wrh-s2(8%)(P<0.01)。(5)当将两种细胞接种到裸鼠和大鼠体内时,均可形成实体瘤,且 Wrh-f2 可形成稳定的肺转移。建立的具有不同转移潜能的细胞系在模拟恶性肝癌肿瘤的生物学特性方面明显优于肝癌,为体内和体外肝癌转移机制提供了合适的模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51a7/7239898/8f1f37da2370/41598_2020_65338_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51a7/7239898/2f9255d846a1/41598_2020_65338_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51a7/7239898/cc764e31bb65/41598_2020_65338_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51a7/7239898/37893ec93424/41598_2020_65338_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51a7/7239898/70c20caf07d4/41598_2020_65338_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51a7/7239898/00885a814bd5/41598_2020_65338_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51a7/7239898/a6d1f6f02e46/41598_2020_65338_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51a7/7239898/11b7bdaaba49/41598_2020_65338_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51a7/7239898/828567c19ed4/41598_2020_65338_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51a7/7239898/eb43c3f5285c/41598_2020_65338_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51a7/7239898/8f1f37da2370/41598_2020_65338_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51a7/7239898/2f9255d846a1/41598_2020_65338_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51a7/7239898/cc764e31bb65/41598_2020_65338_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51a7/7239898/37893ec93424/41598_2020_65338_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51a7/7239898/70c20caf07d4/41598_2020_65338_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51a7/7239898/00885a814bd5/41598_2020_65338_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51a7/7239898/a6d1f6f02e46/41598_2020_65338_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51a7/7239898/11b7bdaaba49/41598_2020_65338_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51a7/7239898/828567c19ed4/41598_2020_65338_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51a7/7239898/eb43c3f5285c/41598_2020_65338_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51a7/7239898/8f1f37da2370/41598_2020_65338_Fig10_HTML.jpg

相似文献

1
Establishment of rat liver cancer cell lines with different metastatic potential.建立具有不同转移潜能的大鼠肝癌细胞系。
Sci Rep. 2020 May 20;10(1):8329. doi: 10.1038/s41598-020-65338-w.
2
Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.通过体内筛选建立具有独特转移特性的肝癌细胞系,并通过cDNA微阵列筛选转移相关基因。
J Cancer Res Clin Oncol. 2003 Jan;129(1):43-51. doi: 10.1007/s00432-002-0396-4. Epub 2002 Dec 4.
3
[Establishment of human hepatocellular carcinoma cell line with spontaneous pulmonary metastasis through in vivo selection].[通过体内筛选建立具有自发肺转移的人肝癌细胞系]
Zhonghua Yi Xue Za Zhi. 2002 May 10;82(9):601-5.
4
Modification of an in vivo lung metastasis model of hepatocellular carcinoma by low dose N-nitrosomorpholine and diethylnitrosamine.低剂量N-亚硝基吗啉和二乙基亚硝胺对肝癌体内肺转移模型的改良
Clin Exp Metastasis. 2005;22(5):441-7. doi: 10.1007/s10585-005-2807-9.
5
Establishment of an in vivo highly metastatic rat hepatocellular carcinoma model.建立一种体内高转移性大鼠肝细胞癌模型。
Jpn J Cancer Res. 1999 Nov;90(11):1196-202. doi: 10.1111/j.1349-7006.1999.tb00695.x.
6
Biological characteristics of fluorescent protein-expressing human hepatocellular carcinoma xenograft model in nude mice.荧光蛋白表达的人肝癌裸鼠移植瘤模型的生物学特性
Eur J Gastroenterol Hepatol. 2008 Nov;20(11):1077-84. doi: 10.1097/MEG.0b013e3283050a67.
7
A decade's studies on metastasis of hepatocellular carcinoma.关于肝细胞癌转移的十年研究。
J Cancer Res Clin Oncol. 2004 Apr;130(4):187-96. doi: 10.1007/s00432-003-0511-1. Epub 2003 Dec 18.
8
Establishment of rat hepatocellular carcinoma cell lines with differing metastatic potential in nude mice.在裸鼠中建立具有不同转移潜能的大鼠肝癌细胞系。
Int J Cancer. 2001 Mar 15;91(6):797-802. doi: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1140>3.0.co;2-#.
9
[A nude mouse model of hepatocellular carcinoma single cell-derived organ site-specific metastasis].[肝癌单细胞来源的器官位点特异性转移裸鼠模型]
Zhonghua Gan Zang Bing Za Zhi. 2012 Jul;20(7):532-6. doi: 10.3760/cma.j.issn.1007-3418.2012.07.011.
10
[Establishment of human ovarian carcinoma cell lines with directional highly lymphatic metastasis and study of their biological characteristics].[具有定向高淋巴转移特性的人卵巢癌细胞系的建立及其生物学特性研究]
Zhonghua Fu Chan Ke Za Zhi. 2007 Jul;42(7):482-6.

引用本文的文献

1
A Novel Rat Model to Simulate Positive Margins in the Wound Bed of a Resected Sarcoma.一种模拟切除肉瘤伤口床切缘阳性的新型大鼠模型。
Plast Reconstr Surg Glob Open. 2024 Nov 27;12(11):e6317. doi: 10.1097/GOX.0000000000006317. eCollection 2024 Nov.
2
Long non-coding RNA CASC7 is a promising serum biomarker for hepatocellular carcinoma.长链非编码 RNA CASC7 是一种有前途的肝细胞癌血清标志物。
BMC Gastroenterol. 2023 Sep 21;23(1):324. doi: 10.1186/s12876-023-02961-7.
3
The distribution of liver cancer stem cells correlates with the mechanical heterogeneity of liver cancer tissue.

本文引用的文献

1
Hepatocyte homeostasis for chromosome ploidization and liver function is regulated by Ssu72 protein phosphatase.Ssu72 蛋白磷酸酶调控肝细胞的染色体倍性和肝功能的稳态。
Hepatology. 2016 Jan;63(1):247-59. doi: 10.1002/hep.28281. Epub 2015 Nov 26.
2
S100A9 promotes human hepatocellular carcinoma cell growth and invasion through RAGE-mediated ERK1/2 and p38 MAPK pathways.S100A9通过RAGE介导的ERK1/2和p38丝裂原活化蛋白激酶途径促进人肝癌细胞的生长和侵袭。
Exp Cell Res. 2015 Jun 10;334(2):228-38. doi: 10.1016/j.yexcr.2015.04.008. Epub 2015 Apr 20.
3
Hepatocellular carcinoma tumour markers: current role and expectations.
肝癌干细胞的分布与肝癌组织的力学异质性相关。
Histochem Cell Biol. 2021 Jul;156(1):47-58. doi: 10.1007/s00418-021-01979-w. Epub 2021 Mar 12.
肝细胞癌肿瘤标志物:当前作用与期望
Best Pract Res Clin Gastroenterol. 2014 Oct;28(5):843-53. doi: 10.1016/j.bpg.2014.07.018. Epub 2014 Aug 22.
4
Therapeutic effect of a multi-targeted imidazolium compound in hepatocellular carcinoma.一种多靶点咪唑鎓化合物在肝细胞癌中的治疗效果。
Biomaterials. 2014 Aug;35(26):7479-87. doi: 10.1016/j.biomaterials.2014.05.022. Epub 2014 Jun 6.
5
SERPINA5 inhibits tumor cell migration by modulating the fibronectin-integrin β1 signaling pathway in hepatocellular carcinoma.丝氨酸蛋白酶抑制剂 A5 通过调节肝癌细胞中纤维连接蛋白-整合素 β1 信号通路抑制肿瘤细胞迁移。
Mol Oncol. 2014 Mar;8(2):366-77. doi: 10.1016/j.molonc.2013.12.003. Epub 2013 Dec 18.
6
Autophagy inhibition suppresses pulmonary metastasis of HCC in mice via impairing anoikis resistance and colonization of HCC cells.自噬抑制通过削弱 HCC 细胞的失巢凋亡抗性和定植能力来抑制小鼠 HCC 的肺转移。
Autophagy. 2013 Dec;9(12):2056-68. doi: 10.4161/auto.26398. Epub 2013 Oct 1.
7
Clinical usefulness of double biomarkers AFP and PIVKA-II for subdividing prognostic groups in locally advanced hepatocellular carcinoma.双重生物标志物甲胎蛋白(AFP)和异常凝血酶原(PIVKA-II)在局部晚期肝细胞癌预后分组中的临床应用价值
Liver Int. 2014 Feb;34(2):313-21. doi: 10.1111/liv.12274. Epub 2013 Jul 29.
8
Hepatocytes polyploidization and cell cycle control in liver physiopathology.肝脏生理病理学中的肝细胞多倍体化与细胞周期调控
Int J Hepatol. 2012;2012:282430. doi: 10.1155/2012/282430. Epub 2012 Oct 22.
9
Aberrant cytokeratin 7 expression of centrilobular hepatocytes: a clinicopathological study.肝小叶中央区肝细胞 CK7 表达异常:一项临床病理研究。
Histopathology. 2012 Nov;61(5):857-62. doi: 10.1111/j.1365-2559.2012.04278.x. Epub 2012 Jun 20.
10
Sorafenib in combination with transarterial chemoembolization and bronchial arterial chemoinfusion in the treatment of hepatocellular carcinoma with pulmonary metastasis.索拉非尼联合经动脉化疗栓塞术及支气管动脉化疗灌注治疗肺转移肝细胞癌
Asia Pac J Clin Oncol. 2012 Jun;8(2):156-63. doi: 10.1111/j.1743-7563.2012.01542.x.